GT Biopharma, Inc. (GTBP)
NASDAQ: GTBP · IEX Real-Time Price · USD
7.80
+4.68 (150.00%)
At close: May 20, 2024, 4:00 PM
8.40
+0.60 (7.69%)
After-hours: May 20, 2024, 7:59 PM EDT

GT Biopharma Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019 2018 - 2014
Selling, General & Admin
7.1112.4547.926.289.79
Upgrade
Research & Development
6.478.819.590.491.67
Upgrade
Other Operating Expenses
00004.6
Upgrade
Operating Expenses
13.5821.2657.526.7616.06
Upgrade
Operating Income
-13.58-21.26-57.52-6.76-16.06
Upgrade
Interest Expense / Income
0.210.010.7232.13
Upgrade
Other Expense / Income
-6.19-0.38-0.2218.5320.46
Upgrade
Pretax Income
-7.6-20.88-58.01-28.3-38.65
Upgrade
Net Income
-7.6-20.88-58.01-28.3-38.65
Upgrade
Shares Outstanding (Basic)
11100
Upgrade
Shares Outstanding (Diluted)
11100
Upgrade
Shares Change
26.87%13.19%542.06%29.59%14.50%
Upgrade
EPS (Basic)
-5.64-19.66-61.80-193.50-0.30
Upgrade
EPS (Diluted)
-5.64-19.66-61.80-193.50-0.30
Upgrade
Free Cash Flow
-8.85-15.22-15.61-7.26-3.46
Upgrade
Free Cash Flow Per Share
-6.57-14.32-16.63-49.68-30.66
Upgrade
EBITDA
-7.38-20.88-57.3-25.29-36.52
Upgrade
Depreciation & Amortization
00000
Upgrade
EBIT
-7.38-20.88-57.3-25.29-36.52
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).